These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12866298)

  • 1. [Hormone therapy, chemotherapy and immunotherapy in breast carcinoma. The best strategy for your patient].
    Sayer HG; Höffken K
    MMW Fortschr Med; 2003 Jun; 145(24):40-2. PubMed ID: 12866298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiestrogen therapy in the treatment of breast neoplasms].
    Alba E; Ragonesi G; Colla F; Mazzoleni A; Farina C
    Minerva Ginecol; 2002 Jun; 54(3):245-51. PubMed ID: 12063440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiestrogen treatment in postmenopausal patients with metastatic breast cancer].
    Lindberg H; Nielsen DL; Tuxen M; Kamby C
    Ugeskr Laeger; 2007 Sep; 169(37):3096-100. PubMed ID: 17877958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevention, detection, and management of breast cancer.
    Houssami N; Cuzick J; Dixon JM
    Med J Aust; 2006 Mar; 184(5):230-4. PubMed ID: 16515434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upstaging tamoxifen? New classes of drugs emerging for breast cancer.
    Twombly R
    J Natl Cancer Inst; 2002 Apr; 94(7):474-5. PubMed ID: 11929942
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of aromatase inhibitors in the treatment of breast neoplasms. An evaluation of clinical efficacy and the tolerability profile].
    Porpiglia M; Genta F; Vicelli R; De Nicola B; Ferraris F; Piccinno R; Benedetto C
    Minerva Ginecol; 2002 Apr; 54(2):115-31. PubMed ID: 12032450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toremifene and letrozole for advanced breast cancer.
    Med Lett Drugs Ther; 1998 Apr; 40(1024):43-5. PubMed ID: 9580744
    [No Abstract]   [Full Text] [Related]  

  • 8. Is low-dose tamoxifen useful for the treatment and prevention of breast cancer?
    Wu K; Brown P
    J Natl Cancer Inst; 2003 Jun; 95(11):766-7. PubMed ID: 12783921
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormones 'R' us.
    Sledge GW
    Clin Breast Cancer; 2002 Jan; 2(4):251. PubMed ID: 11899355
    [No Abstract]   [Full Text] [Related]  

  • 10. [The ATAC study on adjuvants in breast cancer].
    Bravi S
    Suppl Tumori; 2004; 3(4):S15. PubMed ID: 15206200
    [No Abstract]   [Full Text] [Related]  

  • 11. Tamoxifen vs the aromatase inhibitors: news from San Antonio, 2001.
    Munster PN; Horton J
    Cancer Control; 2001; 8(6):478-9. PubMed ID: 11807416
    [No Abstract]   [Full Text] [Related]  

  • 12. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
    Howell A; Cuzick J; Baum M; Buzdar A; Dowsett M; Forbes JF; Hoctin-Boes G; Houghton J; Locker GY; Tobias JS;
    Lancet; 2005 Jan 1-7; 365(9453):60-2. PubMed ID: 15639680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of high dose raloxifene in selected patients with advanced breast carcinoma.
    Gradishar W; Glusman J; Lu Y; Vogel C; Cohen FJ; Sledge GW
    Cancer; 2000 May; 88(9):2047-53. PubMed ID: 10813716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The ATAC study on adjuvants in breast cancer. What kind of repercussions will it have on clinical practice?].
    Gamucci T
    Suppl Tumori; 2004; 3(4):S16. PubMed ID: 15206201
    [No Abstract]   [Full Text] [Related]  

  • 15. Overview of randomized trials of systemic adjuvant therapy.
    Ravdin PM
    Cancer Treat Res; 2000; 103():157-81. PubMed ID: 10948446
    [No Abstract]   [Full Text] [Related]  

  • 16. New options in the prevention and treatment of breast carcinoma.
    Galleshaw J
    J Med Assoc Ga; 2003; 92(1):19-22. PubMed ID: 12743901
    [No Abstract]   [Full Text] [Related]  

  • 17. [Advances in the treatment of breast carcinoma. New therapy schedules with astonishing success quotas].
    Aumiller J
    MMW Fortschr Med; 2006 Mar; 148(12):4-6, 8. PubMed ID: 16625995
    [No Abstract]   [Full Text] [Related]  

  • 18. Breast cancer. Clinical practice guidelines in oncology.
    Carlson RW; Allred DC; Anderson BO; Burstein HJ; Carter WB; Edge SB; Erban JK; Farrar WB; Goldstein LJ; Gradishar WJ; Hayes DF; Hudis CA; Jahanzeb M; Kiel K; Ljung BM; Marcom PK; Mayer IA; McCormick B; Nabell LM; Pierce LJ; Reed EC; Smith ML; Somlo G; Theriault RL; Topham NS; Ward JH; Winer EP; Wolff AC;
    J Natl Compr Canc Netw; 2009 Feb; 7(2):122-92. PubMed ID: 19200416
    [No Abstract]   [Full Text] [Related]  

  • 19. Navigating the Challenges of Endocrine Treatments in Premenopausal Women with ER-Positive Early Breast Cancer.
    Colleoni M; Munzone E
    Drugs; 2015 Aug; 75(12):1311-21. PubMed ID: 26177891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended therapy with letrozole and ovarian suppression in premenopausal patients with breast cancer after tamoxifen.
    Ruddy KJ; DeSantis SD; Barry W; Guo H; Block CC; Borges V; Winer EP; Partridge AH
    Clin Breast Cancer; 2014 Dec; 14(6):413-6. PubMed ID: 24970714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.